Government Not Immune To E-Discovery Costs
Client Alert | 1 min read | 03.16.07
In AAB Joint Venture v. United States (Feb. 28, 2007), the Court of Federal Claims held that Government email files stored on backup tapes were discoverable, even though producing them could cost "between $85,000 and $150,000 and take thirty days" -- because the government had a duty to preserve the evidence once plaintiff filed its request for equitable adjustment, and "the Court cannot relieve Defendant of its duty to produce those documents merely because Defendant has chosen a means to preserve the evidence which makes ultimate production of relevant documents expensive." But the Court declined to decide immediately whether the Government should bear the costs of restoring and producing all the responsive documents, instead ordering a "phased approach" in which (1) the government will restore one-quarter of the records at its own expense and (2) based on the content of those records, the Court will decide whether additional restorations are "likely to lead to relevant evidence and consequently who should bear the cost for additional restoration."
Contacts
Insights
Client Alert | 7 min read | 09.14.26
AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development
Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage.
Client Alert | 6 min read | 09.14.26
Mental Health Parity Bulletin Restates Best Practices for Evaluating Compliance
Client Alert | 6 min read | 09.11.26
It’s LIVE: The Cyber Resilience Act Reporting Is Mandatory as of Today - 11 September 2026
Client Alert | 10 min read | 09.11.26
Mining, Indigenous Consultation Rights, and Investment Treaty Protection

